Research programme: cannabis based therapeutics - Canopy Growth/Entourage Phytolab/

Drug Profile

Research programme: cannabis based therapeutics - Canopy Growth/Entourage Phytolab/

Alternative Names: Cannabis-based therapeutics - Entourage Phytolab

Latest Information Update: 14 Jul 2016

Price : $50

At a glance

  • Originator Canopy Growth; Entourage Phytolab
  • Class Cannabinoids
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Research Unspecified

Most Recent Events

  • 28 Jun 2016 Research in Undefined indication in Brazil before June 2016
  • 28 Jun 2016 Canopy Growth and Entourage agree to co-develop cannabis based therapeutics in Brazil
  • 28 Jun 2016 Entourage announces intention to submit for market approval to ANVISA (Brazilian health surveillance agency) in 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top